Effects of a selective A1-adenosine receptor agonist on heart rate and Heart Rate Variability during permanent Atrial Fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 11 II, 1998, Pages 2459-2464

  Piot, Olivier ^a   Chauvel, Christophe ^a   Lazarus, Arnaud ^a   Pellerin, Denis ^a   David, Didier ^a   Leneveut Ledoux, Laurence ^a   Guize, Louis ^a   Le Heuzey, Jean Yves ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

A1 adenosine receptor; Adenosine; Atrial fibrillation; Heart rate; Heart rate variability

Indexed keywords

6 N CYCLOHEXYL 2' O METHYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXERCISE TEST; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL;

ADENOSINE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 0031753484     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb01201.x     Document Type: Article

References (15)

1. Lewis RV, McMurray J, McDevitt DG. Effects of atenolol, verapamil and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. J Cardiovasc Pharmacol 1989; 13:1-6.
2. Zohle RG, Brewington J, Olukotun AY, et al. Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation. Am J Cardiol 1987; 60:39D-45D.
3. Frey B, Heinz G, Binder T, et al. Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. Am Heart J 1995; 129:58-65.
4. Stein KM, Borer JS, Hochreiter C, et al. Variability of the ventricular response in atrial fibrillation and prognosis in chronic non ischemic mitral regurgitation. Am J Cardiol 1994; 74:906-911.
5. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065.
6. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine. Circulation 1991; 83:1499-1509.
7. Ang EL, Chan WL, Cleland JGF. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation. Br Heart J 1990; 64:256-260.
8. Sarter BH, Marchlinski FE. Redefining the role of digoxin in the treatment of atrial fibrillation. Am J Cardiol 1992; 69:71-81.
9. Wang D, Schryock JC, Belardinelli L. Cellular basis for the negative dromotropic effect of adenosine on rabbit single atrioventricular nodal cells. Circ Res 1996; 78:697-706.
10. Martinyuk AE, Kane KA, Cobbe SM, et al. Nitric oxide mediates the antiadrenergic effect of adenosine on calcium current in isolated rabbit atrioventricular nodal cells. Pflug Arch 1996; 431:452-457.
11. Piot O, Halimi F, Estrugo B, et al. Behaviour of RR interval dynamics in paroxysmal atrial fibrillation episodes. (abstract) Circulation 1995; 92:71.
12. Waktare JEP, Hnatkova K, Baiyan X, et al. Fluctuations in ventricular cycle lengths prior to termination of paroxysmal atrial fibrillation. (abstract) Circulation 1997; 96:76.
13. van den Berg MP, Haaksma J, Brouwer J, et al. Heart rate variability in patients with atrial fibrillation is related to vagal tone. Circulation 1997; 96:1209-2116.
14. Hayano J, Sakata S, Okada A, et al. Circadian rhythms of atrioventricular conduction properties in chronic atrial fibrillation with and without heart failure. J Am Coll Cardiol 1998; 31:158-166.
15. Janse MJ. The role of the atrioventricular node in atrial fibrillation. In: SB Olsson, MA Allessie, RWF Campbell (eds.): Atrial Fibrillation: Mechanisms and Therapeutical Strategies. Armonk, NY, Futura Publishing, 1994, pp. 127-140.